ISPUB.com / IJID/5/2/4457
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Infectious Diseases
  • Volume 5
  • Number 2

Original Article

A Review Of Lemierre Syndrome

M Baig, J Rasheed, D Subkowitz, J Vieira

Keywords

fusobacterium necrophorum, internal jugular vein, lemierre syndrome, necrobacillosis, thrombophlebitis

Citation

M Baig, J Rasheed, D Subkowitz, J Vieira. A Review Of Lemierre Syndrome. The Internet Journal of Infectious Diseases. 2005 Volume 5 Number 2.

Abstract

Lemierre syndrome (postanginal septicemia) is caused by an acute oropharyngeal infection with secondary septic thrombophlebitis of the internal jugular vein and frequent metastatic infections. A high degree of clinical suspicion is necessary for diagnosis. Fusobacterium necrophorum (F necrophorum) is the usual etiologic agent.

The disease progresses in several steps. The first stage is the primary infection, which is usually a pharyngitis. This is followed by local invasion of the lateral pharyngeal space and Internal Jugular Vein (IJV) septic thrombophlebitis, and finally, the occurrence of metastatic complications. A sore throat is the most common symptom during the primary infection. During invasion of the lateral pharyngeal space and IJV septic thrombophlebitis, a swollen and/or tender neck is the most common finding and should be considered a red flag in patients with current or recent pharyngitis. The most common site of metastatic infection is the lungs. In contrast to the preantibiotic era, cavitating pneumonia and septic arthritis are now uncommon. Most patients had fever at some stage during the course of the disease.


We conclude that the typical course of the disease has changed since Lemierre's original description most likely as a consequence of widespread antibiotic use for pharyngeal infections. Mortality is low now a days, but significant morbidity still occurs, which is likely preventable by early diagnosis and treatment. The pathophysiology, natural history, diagnostic methods for internal jugular vein thrombosis, and management are discussed here.

 

Introduction

Lemierre syndrome, also known as postanginal sepsis or necrobacillosis, is an uncommon but potentially life-threatening complication of acute pharyngotonsillitis. Anaerobic oropharyngeal infection may result in septic thrombophlebitis of the ipsilateral internal jugular vein with subsequent septicemia and septic embolization, which cause metastatic abscesses, commonly in the lungs and less commonly in the large joints. In 1936, Lemierre (1) gave a detailed description of the condition reported by Schottmuller in 1918 that came to bear Lemierre's name and indicated that the clinical findings were “so characteristic that mistake is almost impossible.” In the preantibiotic era, Lemierre syndrome was common and often followed a fulminant course, with a mortality rate of 90% (1). In recent years, the widespread use of antibiotics in the management of acute oropharyngeal infection has led to a rapid decline in the prevalence of Lemierre syndrome. Lack of familiarity with this condition, which patients may have when they present to the ear, nose, and throat surgeon, physician, or pediatrician, can lead to serious delay in diagnosis and may explain why it has been referred to as “a forgotten disease” (2).

Over the past 2 decades, occasional case reports and literature reviews pertaining to Lemierre syndrome have been published in the medicine, pediatrics, and otorhinolaryngology literature (2,3,4,5,6,7,8,9,10,11).The purpose of this review is to heighten physician's awareness of this syndrome to expedite diagnosis of a syndrome that often manifests as nonspecific clinical and chest radiographic findings.

Etiology and Patient Characteristics

Most cases occur in patients aged 16–25 years, but cases occasionally occur in younger patients and older patients as well. Most patients are previously healthy individuals. The etiology of Lemierre syndrome is found to be Fusobacterium necrophorum (F. necrophorum) in 81.7% of the cases, as demonstrated by positive cultures from clinical specimens, usually blood. However, several other organisms are found to be reported, alone (5.5%) or in combination with F. necrophorum (10.1%). These include Bacteroides asaccharolyticus, Bacteroides fragilis, Bacteroides gracilis, Bacteroides melaninogenicus, Bacteroides distasonis, Bacteroides uniformis, Peptostreptococcus, Group B and C Streptococcus, Streptococcus oralis, Staphylococcus epidermidis, Enterococcus sp., Proteus mirabilis, Eubacterium sp., Eikenella corrodens, lactobacilli, and Candida sp. Cultures are negative in 12.8% of cases. (12)

Pathogenesis

F. necrophorum has an unusual ability to cause severe disease as a primary pathogen in previously healthy people with intact anatomical barriers (19, 21, 23, 26,27,28,29), unlike other anaerobic bacteria. The disease progresses in several steps. The first stage is the primary infection, which is usually pharyngitis (19, 21, 23, 26,27,28,29). This is followed by local invasion to the lateral pharyngeal space and internal jugular vein (IJV) septic thrombophlebitis, and finally, the occurrence of metastatic complications.

In the majority of cases, a temporal pattern is obvious in that these stages occur in an orderly fashion and correspond to distinct clinical manifestations. (12) Below, the pathophysiology of each stage is reviewed:

Primary Infection

The palatine tonsils and peritonsillar tissue are found to be the primary source of infection in most cases (87.1%). Odontogenic infections (1.8%) and mastoiditis (2.7%) also occur in some patients. Additional sources have been reported in other series, including parotitis, sinusitis and primary infection in the skin or subcutaneous tissues of the head and neck. (12)

The clinical findings in this stage depend on the primary site of infection. Since pharyngitis made up the vast majority of cases, a sore throat and evidence of pharyngeal inflammation are the primary findings. Fever occurs in about 82.5% of cases, but not necessarily at the time of initial presentation. Gastrointestinal complaints such as abdominal pain, nausea, and vomiting are present in 49.5% of cases. At this point in presentation, there are no “red flags” that would suggest the etiology. Many patients have only subtle findings, such as hyperemia of the pharynx.

The percentage of cases of F. necrophorum pharyngitis that progress to invasion of the lateral pharyngeal space and IJV septic thrombophlebitis is unknown. (12, 22)

The time interval between the oropharyngeal infection and the onset of the second stage is usually less than 1 week. In some cases, signs and symptoms related to oropharyngeal infection have cleared (at times without antibiotic therapy) by the time IJV thrombosis developed. (12)

Invasion of the Lateral Pharyngeal Space and IJV Thrombophlebitis

In the past, it was thought that IJV thrombophlebitis was initiated in the tonsillar and peritonsillar veins with subsequent spread to the IJV. However, it is likely that the most common mechanism involves spread of infection from peritonsillar tissue to the adjacent lateral pharyngeal space, mainly via lymphatic vessels (18). It is the infection of this compartment that can cause complications such as thrombophlebitis of the IJV and severe sepsis with metastatic infections (19, 21, 23, 26,27,28,29).

The lateral pharyngeal space is divided by the styloid process into an anterior (muscular) and a posterior (neurovascular) compartment. The posterior neurovascular compartment includes the IJV, the carotid artery, the vagus nerve, lymph nodes, cranial nerves X-XII, and the cervical sympathetic trunk. The clinical findings of the invasion of this compartment result from compromise of these vital structures.

Carotid artery rupture has occurred and is the most catastrophic complication of this stage; Horner syndrome may occur if the sympathetic trunk is involved. Paralysis of the trapezius muscle has been reported, most likely secondary to compromise of the spinal accessory nerve (3). Dysphagia occurs in 17.4% of patients. The most frequent finding (52.2%) at this stage is a tender and/or swollen neck, and this should be considered a warning sign in a patient with pharyngitis. The pain and swelling may extend from the angle of the jaw and along the sternocleidomastoid muscle, sometimes with associated trismus (9.1%) (13, 15, 17, 28, 30,31,32). Pain when turning the head away from the involved site may occur as a consequence of irritation of the sternocleidomastoid muscle. Spasm of the sternocleidomastoid muscle may occur as well. The thrombosed jugular vein is rarely palpable. It must be remembered that local findings may be subtle or absent, particularly if the infection selectively affects the posterior compartment of the lateral pharyngeal space. No significant neck findings are present in 47.7% of the patients. (12)

Metastatic Complications

Once the infection involves the IJV, it may cause bacteremia with hematogenous spread to other sites. The first sign of this complication may be fever, soon thereafter accompanied by intense rigor. The lungs are by far the most common metastatic target (79.8%), followed by the joints (16.5%). The typical pulmonary findings in Lemierre syndrome reported previously are those resembling septic pulmonary embolism with chest X-ray findings of cavitating pneumonia, similar to what is seen in right-sided bacterial endocarditis with septic embolization. Associated pleural effusions are common (43.1%) and may precede the appearance of pulmonary infiltrates. A normal chest X-ray is present in 19.2% of cases, and only 31.1% of patients had radiologic evidence of cavitation. Empyema and lung abscess may be seen, and both pneumatoceles and pneumothorax have been described. Frank respiratory failure requiring ventilatory support occurs in 15.5% of cases. (12)

The second most common sites of septic embolization are the joints, with the hip, shoulders, and knees most frequently involved (10, 15, 20, 24,25,26). The frequency of joint involvement is 16.5% now, significantly lower than in the preantibiotic era (66.6%). Other sites of septic dissemination include hepatic or splenic abscesses (2.7%). However, splenomegaly and hepatomegaly are common (15.5%) and are not necessarily associated with liver or hepatic abscesses (24). Mild hyperbilirubinemia with slight elevation of liver enzyme levels has been reported to be a common finding (8). Renal involvement with proteinuria and hematuria has been described as the predominant manifestation in a patient (14). When renal complications develop, the syndrome may be mistaken for poststreptococcal glomerulonephritis. Metastatic spread of infection through embolization complicated all the cases described by Lemierre. However, this seems to be preventable by early antibiotic treatment (16, 25)

Outcome

In the cases described by Lemierre in the preantibiotic era, the outcome was fatal with rapidly progressing septicemia (16, 25). The outcome of the syndrome after appropriate therapy has been instituted is favorable in most patients, although adult respiratory distress syndrome has been reported, and fatal cases have been seen even in the antibiotic era. Clearly, however, if it is recognized and appropriately treated, Lemierre syndrome has a good prognosis in most cases. (12)

Diagnosis

Lemierre himself stated (25) that: The appearance and repetition several days after the onset of a sore throat (and particularly of a tonsillar abscess) of severe pyrexial attacks with an initial rigor, or still more certainly the occurrence of pulmonary infarcts and arthritic manifestations, constitute a syndrome so characteristic that mistake is almost impossible.

In fact, the diagnosis of Lemierre syndrome on the basis of clinical grounds should be considered if the physician is aware of the existence of the disease. However, it is rare today and has been said to be “forgotten” by the medical community (13, 24, 27, 28,31). Most patients have evidence of metastatic complications by the time of diagnosis. (12)

Management

The approach to a patient with pharyngitis and a tender/swollen neck should be aggressive. Blood cultures should be obtained, evidence of IJV thrombophlebitis should be sought, and anaerobic coverage with metronidazole or clindamycin should be initiated. Diagnostic methods to detect IJV thrombophlebitis include Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI) and ultrasound.

Ultrasound, the least expensive, may reveal an echogenic region within a dilated jugular vein, or a complex mass of solid and cystic components. However, it may miss a fresh thrombus with low echogenicity, and imaging the area beneath the clavicle may be technically difficult. CT scans are better able to demonstrate the anatomy and the presence of abscesses that need to be drained. This method may also reveal low attenuation intraluminal filling defects, and adjacent soft tissue swelling.

Some authors have recommended CT as the primary diagnostic method, with ultrasound being the best test for follow-up once the anatomy has been well defined. If the patient has infection arising from the mastoid, the presence of intracerebral vein thrombosis specifically needs to be excluded (usually with MRI). (33,34,35,36,37,38,39,40,41,42)

For the treatment of Lemierre syndrome today, we certainly have more tools than Lemierre had at his disposal. The only recognized treatment in the preantibiotic era was ligation of the IJV on the affected side in an attempt to prevent septicemic spread. Today, the mainstay of treatment is prolonged antibiotic therapy (4–6 weeks), which seems necessary to eradicate the infection, probably because of its endovascular nature. F necrophorum is usually susceptible in vitro to penicillin, clindamycin, or metronidazole. (43, 44) However, deaths caused by a β-lactamase–producing strain have been reported. (45) In addition, data indicate an increasing resistance to erythromycin, commonly used for empirical antimicrobial treatment of oropharyngeal infections. A study of cases during 1990-2000 showed that, although F necrophorum isolates remain fully susceptible to metronidazole, resistance to penicillin was 2% and to erythromycin was 15% in all isolates. This observation may be of potential clinical relevance because it could partly account for the perceived increase in the incidence of Lemierre syndrome in recent years. (46)

Considering the devastating consequences that result frequently from this infection, we suggest initial empirical therapy for suspected or confirmed F necrophorum sepsis and Lemierre syndrome with a β-lactamase–resistant antimicrobial agent until results of antimicrobial susceptibility tests are available. The duration of antibacterial therapy should be prolonged; most patients should be treated for at least 4 to 6 weeks.

Use of anticoagulant therapy for necrobacillosis-associated thrombosis is controversial. Because the illness is rare, no published data have assessed the efficacy of anticoagulation. Some experts argue against its use because of the potential risk of facilitating the spread of infection. However, others have advocated its use on the basis of data from gynecological literature that support the use of heparin for treatment of pelvic septic thrombophlebitis, especially in patients with progressive clot propagation or with embolization despite adequate antimicrobial therapy. Finally, in patients with uncontrolled sepsis and ongoing evidence of septic emboli despite appropriate medical therapy, surgical ligation or excision of the IJV should be considered. Fortunately, this treatment is rarely needed today. (47,48)

Correspondence to

Muhammad Ahsan Baig, MD Department of Internal Medicine Long Island College Hospital, 339 Hicks street, Brooklyn, NY 11201 Tel: (646) 223-0271 Fax: (718) 780-1300 E-Mail: drahsanbaig@yahoo.com

References

1. Abele-Horn M, Emmerling P, Mann JF. Lemierre's syndrome with spondylitis and pulmonary and gluteal abscesses associated with Mycoplasma pneumoniae pneumonia. Eur J Clin Microbiol Infect Dis 20: 263-266, 2001.
2. Adams J, Capistrant T, Crossley K, Johanssen R, Liston S. Fusobacterium necrophorum septicemia. JAMA 250: 35, 1983.
3. Agarwal R, Arunachalam PS, Bosman DA. Lemierre's syndrome: A complication of acute oropharyngitis. J Laryngol Otol 114: 545-547, 2000.
4. Ahkee S, Srinath I, Huang A, Raff MJ, Ramirez JA. Lemierres syndrome: Postanginal sepsis due to anaerobic oropharyngeal infection. Ann Otol Rhinol Laryngol 103: 308-310, 1994.
5. Alifano M, Venissac N, Guillot F, Mouroux J. Lemierre's syndrome with bilateral empyema thoracis. Ann Thorac Surg 69: 930-931, 2000.
6. Alvarez A, Schreiber JR. Lemierre's syndrome in adolescent children-anaerobic sepsis with internal jugular vein thrombophlebitis following pharyngitis. Pediatrics 96: 354-359, 1995.
7. Avinash K, et al. Lemierre's syndrome following mastoiditis. Infect Med 15: 323-325, 1998.
8. Baddour LM, Land MA, Barrett FF, Rivara FP, Bruce WM, Bisno AL. Hepatobiliary abnormalities associated with postanginal sepsis. Common manifestations of an uncommon disease. Diagn Micriobiol Infect Dis 4: 19-28, 1986.
9. Baker J, Winer-Muram HT, Grey SW. Lemierre syndrome. South Med J 89: 1021-1023, 1996.
10. Beldman TF, Teunisse HA, Schouten TJ. Septic arthritis of the hip by Fusobacterium necrophorum after tonsillectomy: A form of Lemierre syndrome? Eur J Pediatr 156: 856-857, 1997.
11. Bielecki JW. [Septic syndrome with a pulmonary focus]. Schweiz Rundsch Med Prax 80: 1030-1033, 1991.
12. Chirinos, Julio A M.D, Lichtstein, Daniel M.D, Garcia, Javier M.D, Tamariz, Leonardo J M.D, M.P.H. The Evolution of Lemierre Syndrome: Report of 2 Cases and Review of the Literature. Volume 81(6), November 2002, pp 458-465
13. Carlson ER, Bergamo DF, Coccia CT. Lemierre's syndrome: Two cases of a forgotten disease. J Oral Maxillofac Surg 52: 74-78, 1994.
14. Carrie S, Fenton PA. Necrobacillosis-an unusual case of pharyngotonsillitis. J Laryngol Otol 108: 1097-1098, 1994.
15. Cosgrove EF, Colodny SM, Pesce RR. Adult respiratory distress syndrome as a complication of postanginal sepsis. Chest 103: 1628-1629, 1993.
16. Courmont P, Cade A. Sur une septico-pyohemie de l'homme simulant la peste et causee par un streptobacille anaerobie. Arch Med Exp Anat Pathol no. 4, 1900.
17. Dykhuizen RS, Olson ES, Clive S, Douglas JG. Necrobacillosis (Lemierre's syndrome): A rare cause of necrotizing pneumonia. Eur Respir J 7: 2246-2248, 1994.
18. Falkler Jr, WA Enwonwu CO. Microbiological understandings and mysteries of noma. Oral Dis 5: 150-155, 1999.
19. Golpe R, Marin B, Alonso M. Lemierre's syndrome (necrobacillosis). Postgrad Med J 75: 141-144, 1999.
20. Gong J, Garcia J. Lemierre's syndrome. Eur Radiol 9: 672-674, 1999.
21. Hagelskjaer Kristensen L, Prag J. Human necrobacillosis, with emphasis on Lemierre's syndrome. Clin Infect Dis 31: 524-532, 2000.
22. Harar RP, MacDonald A, Pullen D, Ganesan S, Prior AJ. Lemierre's syndrome: Are we underdiagnosing this life-threatening infection? J Otorhinolaryngol Relat Spec 58: 178-181, 1996.
23. Henry S, deMaria A, McCabe WR. Bacteremia due to Fusobacterium species. Am J Med 75: 225-232, 1983.
24. Koay CB, Heyworth T, Burden P. Lemierre syndrome-a forgotten complication of acute tonsillitis. J Laryngol Otol 109: 657-661, 1995.
25. Lemierre A. On certain septicemias due to anaerobic organisms. Lancet 1: 701-703, 1936.
26. Leugers CM, Clover R. Lemierre's syndrome: Postanginal sepsis. J Am Board Fam Pract 8: 384-391, 1995.
27. Moore-Gillon J, Lee TH, Eykyn SJ, Phillips I. Necrobacillosis: A forgotten disease. Br Med J (Clin Res Ed) 288: 1526-1527, 1984.
28. Screaton NJ, Ravenel JG, Lehner PJ, Heitzman ER, Flower CD. Lemierre syndrome: Forgotten but not extinct-report of four cases. Radiology 213: 369-374, 1999.
29. Sinave CP, Hardy GJ, Fardy PW. The Lemierre syndrome: Suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection. Medicine (Baltimore) 68: 85-94, 1989.
30. Tewfik TL, Husein M, Shapiro RS, Oudjhane K. Lemierre syndrome in an immunocompromised patient. Int J Pediatr Otorhinolaryngol 51: 195-199, 1999.
31. Weesner CL, Cisek JE. Lemierre syndrome: The forgotten disease. Ann Emerg Med 22: 256-258, 1993.
32. Williams A, Nagy M, Wingate J, Bailey L, Wax M. Lemierre syndrome: A complication of acute pharyngitis. Int J Pediatr Otorhinolaryngol 45: 51-57, 1998.
33. Jaffe RB, Koschmann EB. Septic pulmonary emboli. Radiology 1970; 96:527- 532.
34. Julander I. Staphylococcal septicaemia and endocarditis in 80 drug addicts. Scand J Infect Dis 1983; 41:49-54.
35. Huang RM, Naidich DP, Lubat E, Schinella R, Garay SM, McCauley DI. Septic pulmonary emboli: CT-radiographic correlation. AJR 1989; 153:41-45.
36. Kuhlman JE, Fishman EK, Teigen C. Pulmonary septic emboli: diagnosis with CT. Radiology 1990; 174:211-213.
37. Albertyn LE, Alcock MK. Diagnosis of internal jugular vein thrombosis. Radiology 1987; 162:505-508.
38. Wing V, Scheible W. Sonography of jugular vein thrombosis. AJR 1983; 140:333-336.
39. Patel MC, Berman LH, Moss HA. Loss of respiratory phasicity and cardiac pulsatility as a predictor of central neck vein occlusion. Br J Radiol 1997; 70(suppl):7.
40. Patel S, Brennan J. Diagnosis of internal jugular vein thrombosis by computed tomography. J Comput Assist Tomogr 1981; 5:197-200.
41. Fishman EK, Pakter RL, Gayler BW, Wheeler PS, Siegelman SS. Jugular venous thrombosis: diagnosis by computed tomography. J Comput Assist Tomogr 1984; 8:963-968.
42. Braun IF, Hoffman JC, Malko JA, Pettigrew RI, Dannels W, Davis PC. Jugular venous thrombosis: MR imaging. Radiology 1985; 157:357-360.
43. Hagelskjaer Kristensen L, Prag J. Human necrobacillosis, with emphasis on Lemierre's syndrome. Clin Infect Dis. 2000; 31:524-532.
44. Hagelskjaer LH, Prag J, Malczynski J, Kristensen JH. Incidence and clinical epidemiology of necrobacillosis, including Lemierre's syndrome, in Denmark 1990-1995. Eur J Clin Microbiol Infect Dis. 1998; 17:561-565.
45. Levine SR, Twyman RE, Gilman S. The role of anticoagulation in cavernous sinus thrombosis. Neurology. 1988; 38:517-522.
46. Cohen MB, Pernoll ML, Gevirtz CM, Kerstein MD. Septic pelvic thrombophlebitis: an update. Obstet Gynecol. 1983; 62:83-89.
47. Levine SR, Twyman RE, Gilman S. The role of anticoagulation in cavernous sinus thrombosis. Neurology. 1988; 38:517-522.
48. Cohen MB, Pernoll ML, Gevirtz CM, Kerstein MD. Septic pelvic thrombophlebitis: an update. Obstet Gynecol. 1983; 62:83-89.

Author Information

Muhammad Ahsan Baig, M.D.
Department of Medicine, Division of Infectious Disease, Long Island College Hospital and SUNY Downstate Medical Center

Javeria Rasheed, M.D.
Department of Medicine, Division of Infectious Disease, Long Island College Hospital and SUNY Downstate Medical Center

D. Subkowitz, M.D.
Department of Medicine, Division of Infectious Disease, Long Island College Hospital and SUNY Downstate Medical Center

Jeffrey Vieira, M.D.
Department of Medicine, Division of Infectious Disease, Long Island College Hospital and SUNY Downstate Medical Center

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy

Close

Enter the site

Login

Password

Remember me

Forgot password?

Login

SIGN IN AS A USER

Use your account on the social network Facebook, to create a profile on BusinessPress